(Q37783496)

23 August 2017

title

Reciprocal control of 1,25-dihydroxyvitamin D and FGF23 formation involving the FGF23/Klotho system (English)

1 reference

https://api.crossref.org/works/10.2215/CJN.02680310

23 August 2017

Reciprocal Control of 1,25-Dihydroxyvitamin D and FGF23 Formation Involving the FGF23/Klotho System (English)

1 reference

2 July 2024

2

Gérard Friedlander

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20798257

2 July 2024

author name string

Dominique Prié

1

1 reference

23 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20798257

2 July 2024

publication date

26 August 2010

1 reference

full work available at URL

23 August 2017

https://cjasn.asnjournals.org/content/5/9/1717.full.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20798257

http://cjasn.asnjournals.org/cgi/content/abstract/5/9/1717

2 July 2024

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20798257

https://journals.lww.com/01277230-201009000-00029

2 July 2024

1 reference

https://api.crossref.org/works/10.2215/CJN.02680310

Clinical Journal of the American Society of Nephrology

2 July 2024

published in

1 reference

23 August 2017

volume

5

1 reference

23 August 2017

issue

9

1 reference

23 August 2017

page(s)

1717-1722

1 reference

Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes

23 August 2017

cites work

https://api.crossref.org/works/10.2215/CJN.02680310

1

1 reference

Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

2

1 reference

Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

3

1 reference

Pathways for kidney-specific uptake of the steroid hormone 25-hydroxyvitamin D3.

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

4

1 reference

Deficient mineralization of intramembranous bone in vitamin D-24-hydroxylase-ablated mice is due to elevated 1,25-dihydroxyvitamin D and not to the absence of 24,25-dihydroxyvitamin D

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

5

1 reference

Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

6

1 reference

An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia.

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

7

1 reference

The role of mutant UDP-N-acetyl-alpha-D-galactosamine-polypeptide N-acetylgalactosaminyltransferase 3 in regulating serum intact fibroblast growth factor 23 and matrix extracellular phosphoglycoprotein in heritable tumoral calcinosis.

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

8

1 reference

Bone as a source of FGF23: regulation by phosphate?

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

9

1 reference

Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

10

1 reference

Pathogenic role of Fgf23 in Hyp mice.

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

11

1 reference

FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

12

1 reference

Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

14

1 reference

FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

15

1 reference

FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa.

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

16

1 reference

Effect of fibroblast growth factor-23 on phosphate transport in proximal tubules

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

17

1 reference

Human fibroblast growth factor-23 mutants suppress Na+-dependent phosphate co-transport activity and 1alpha,25-dihydroxyvitamin D3 production

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

18

1 reference

Role of the vitamin D receptor in FGF23 action on phosphate metabolism

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

19

1 reference

FGF-23 is elevated by chronic hyperphosphatemia

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

20

1 reference

Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men.

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

21

1 reference

Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men.

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

22

1 reference

Klotho converts canonical FGF receptor into a specific receptor for FGF23

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

23

1 reference

Correlation between hyperphosphatemia and type II Na-Pi cotransporter activity in klotho mice

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

24

1 reference

Regulation of fibroblast growth factor-23 signaling by klotho

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

25

1 reference

Mutation of the mouse klotho gene leads to a syndrome resembling ageing

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

26

1 reference

Immunohistochemical localization of Klotho protein in brain, kidney, and reproductive organs of mice.

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

27

1 reference

The parathyroid is a target organ for FGF23 in rats

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

28

1 reference

Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

29

1 reference

Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

31

1 reference

Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D.

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

32

1 reference

Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

33

1 reference

Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

34

1 reference

Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

35

1 reference

Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

36

1 reference

Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

37

1 reference

Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

38

1 reference

Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency.

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

39

1 reference

Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

40

1 reference

Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients.

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

41

1 reference

Severely reduced production of klotho in human chronic renal failure kidney.

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

42

1 reference

Gene expression analysis of kidneys from transgenic mice expressing fibroblast growth factor-23.

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

43

1 reference

Survival benefits with vitamin D receptor activation: new insights since 2003.

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

44

1 reference

Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the "trade-off" hypothesis

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

45

1 reference

Fibroblast Growth Factor 23 (FGF23) Predicts Progression of Chronic Kidney Disease: The Mild to Moderate Kidney Disease (MMKD) Study

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

46

1 reference

Vitamin D levels and patient outcome in chronic kidney disease

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

47

1 reference

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

48

1 reference

High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients.

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

49

1 reference

Pretreatment serum FGF-23 levels predict the efficacy of calcitriol therapy in dialysis patients.

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

50

1 reference

Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients.

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

51

1 reference

Suppression of aging in mice by the hormone Klotho

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

52

1 reference

Klotho variants and chronic hemodialysis mortality

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

53

1 reference

Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

54

1 reference

Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

55

1 reference

Vitamin D receptor (VDR) gene polymorphism is associated with left ventricular (LV) mass and predicts left ventricular hypertrophy (LVH) progression in end-stage renal disease (ESRD) patients.

2 July 2024

https://api.crossref.org/works/10.2215/CJN.02680310

56

1 reference

2 July 2024

Identifiers

DOI

10.2215/CJN.02680310

1 reference

23 August 2017

1 reference